TTF1 and adenocarcinoma: TTF-1 is expressed in 60–90% of LUAD patients and thyroid carcinomas but is typically absent in adenocarcinomas of other sites and NSCLC squamous cell carcinomas as detected by immunohistochemistry (IHC) [3–6].